HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.

AbstractBACKGROUND:
Recently, it has been reported that TFPI2 (tissue factor pathway inhibitor-2), a Kunitz-type serine proteinase inhibitor, is frequently methylated in human colorectal cancer using a gene expression array-based strategy. The aim of this study therefore was to examine whether the TFPI2 methylation in surgically removed colorectal cancers was correlated to the clinicopathological features.
MATERIALS AND METHODS:
The methylation status of the TFPI2 gene was examined in primary carcinomas and corresponding normal tissues derived from 50 patients with colorectal cancer using quantitative methylation-specific PCR (qMSP), and the correlation between the methylation status and the clinicopathological findings was evaluated. Results. Methylation of the TFPI2 gene was detected in 31 out of the 50 (62%) primary colon carcinomas, suggesting that the methylation of TFPI2 is frequently observed in colorectal cancer. The clinicopathological data were compared with these results. Significant differences were observed between methylation of TFPI2 and histology (p=0.0053) or lymph node metastasis (p=0.0396). These results indicated that TFPI2 was more frequently methylated in well-differentiated advanced colorectal carcinomas.
CONCLUSION:
TFPI2 may act as a tumour suppressor in colorectal carcinomas and TFPI2 methylation may present a potential risk of malignancy in colorectal cancer.
AuthorsKenji Hibi, Tetsuhiro Goto, Yo-Hei Kitamura, Kazuaki Yokomizo, Kazuma Sakuraba, Atsushi Shirahata, Hiroki Mizukami, Mitsuo Saito, Kazuyoshi Ishibashi, Gaku Kigawa, Hiroshi Nemoto, Yutaka Sanada
JournalAnticancer research (Anticancer Res) Vol. 30 Issue 4 Pg. 1205-7 (Apr 2010) ISSN: 1791-7530 [Electronic] Greece
PMID20530429 (Publication Type: Journal Article)
Chemical References
  • Glycoproteins
  • tissue-factor-pathway inhibitor 2
Topics
  • Aged
  • Aged, 80 and over
  • Cell Differentiation (physiology)
  • Colorectal Neoplasms (genetics, pathology)
  • DNA Methylation
  • Female
  • Glycoproteins (genetics)
  • Humans
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: